{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T17:36:46Z","timestamp":1699637806348},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T00:00:00Z","timestamp":1251849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s12185-009-0390-6","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T06:56:26Z","timestamp":1251788186000},"page":"303-310","source":"Crossref","is-referenced-by-count":10,"title":["Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China"],"prefix":"10.1007","volume":"90","author":[{"given":"Hongyan","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyuan","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"390_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin\u2019s lymphoma. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"issue":"7","key":"390_CR2","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103(7):2474\u20139. doi: 10.1182\/blood-2003-09-3080 .","journal-title":"Blood"},{"issue":"7","key":"390_CR3","first-page":"454","volume":"28","author":"XL Yuan","year":"2007","unstructured":"Yuan XL, Li QC, Zou DH, Zhao YZ, Wang YF, Wang Y, et al. Retrospective analysis of 54 patients with high-risk aggressive T-cell non-Hodgkin lymphomas. Zhonghua Xue Ye Xue Za Zhi. 2007;28(7):454\u20137.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"3","key":"390_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood.V99.3.815","volume":"99","author":"M Yamaguchi","year":"2002","unstructured":"Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99(3):815\u201321. doi: 10.1182\/blood.V99.3.815 .","journal-title":"Blood"},{"issue":"1","key":"390_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","volume":"124","author":"GE Janka","year":"2004","unstructured":"Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124(1):4\u201314. doi: 10.1046\/j.1365-2141.2003.04726.x .","journal-title":"Br J Haematol"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2141.2004.05144.x","volume":"127","author":"A Dogan","year":"2004","unstructured":"Dogan A, Morice WG. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol. 2004;127:140\u201354. doi: 10.1111\/j.1365-2141.2004.05144.x .","journal-title":"Br J Haematol"},{"issue":"8","key":"390_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"A L\u00f3pez-Guillermo","year":"1998","unstructured":"L\u00f3pez-Guillermo A, Cid J, Salar A, L\u00f3pez A, Montalb\u00e1n C, Castrillo JM, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL classification. Ann Oncol. 1998;9(8):849\u201355. doi: 10.1023\/A:1008418727472 .","journal-title":"Ann Oncol"},{"issue":"1","key":"390_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/ajcp\/103.1.82","volume":"103","author":"M Fraga","year":"1995","unstructured":"Fraga M, Brousset P, Schlaifer D, Payen C, Robert A, Rubie H, et al. Bone marrow involvement in anaplastic large cell lymphoma: immunohistochemical detection of minimal disease and its progonostic significance. Am J Clin Pathol. 1995;103(1):82\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"390_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3346\/jkms.2004.19.2.229","volume":"19","author":"CO Sung","year":"2004","unstructured":"Sung CO, Ko YH. Bone marrow is involved in less than 10% of patients with nasal-type NK\/T-cell lymphoma at initial diagnosis. J Korean Med Sci. 2004;19(2):229\u201333.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"390_CR10","first-page":"539","volume":"17","author":"LL Siu","year":"2002","unstructured":"Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol. 2002;17(2):539\u201354.","journal-title":"Histol Histopathol"},{"issue":"4","key":"390_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0046-8177(91)90081-Y","volume":"22","author":"P Gaulard","year":"1991","unstructured":"Gaulard P, Kanavaros P, Farcet JP, Rocha FD, Haioun C, Divine M, et al. Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: a study of 38 cases. Hum Pathol. 1991;22(4):331\u20138. doi: 10.1016\/0046-8177(91)90081-Y .","journal-title":"Hum Pathol"},{"issue":"2","key":"390_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2141.1985.tb02819.x","volume":"61","author":"AM Ghani","year":"1985","unstructured":"Ghani AM, Krause JR. Bone marrow biopsy findings in angioimmunoblastic lymphadenopathy. Br J Haematol. 1985;61(2):203\u201313. doi: 10.1111\/j.1365-2141.1985.tb02819.x .","journal-title":"Br J Haematol"},{"issue":"1","key":"390_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10428190701713630","volume":"49","author":"H Tong","year":"2008","unstructured":"Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leuk Lymphoma. 2008;49(1):81\u20137. doi: 10.1080\/10428190701713630 .","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"390_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl VA. Prognostic score for advanced Hodgkin\u2019s disease: International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl J Med. 1998;339(21):1506\u201314. doi: 10.1056\/NEJM199811193392104 .","journal-title":"N Engl J Med"},{"issue":"4","key":"390_CR15","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1182\/blood-2007-01-070300","volume":"110","author":"R Chung","year":"2007","unstructured":"Chung R, Lai R, Wei P, Lee J, Hanson J, Belch AR, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood. 2007;110(4):1278\u201382. doi: 10.1182\/blood-2007-01-070300 .","journal-title":"Blood"},{"key":"390_CR16","first-page":"132","volume":"16","author":"YL Peng","year":"2006","unstructured":"Peng YL, Huang HQ, Zhou ZM, Lin XB, Pang ZH, Guan ZZ. Clinical outcome of 117 patients with peripheral T-cell lymphomas, unspecified. China Oncol. 2006;16:132\u20135.","journal-title":"China Oncol"},{"issue":"2","key":"390_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/cncr.11899","volume":"100","author":"AM Tsimberidou","year":"2004","unstructured":"Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock R. Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series. Cancer. 2004;100(2):342\u20139. doi: 10.1002\/cncr.11899 .","journal-title":"Cancer"},{"issue":"7","key":"390_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/cncr.20531","volume":"101","author":"F Morabito","year":"2004","unstructured":"Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Neri S, et al. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. Cancer. 2004;101(7):1601\u20138. doi: 10.1002\/cncr.20531 .","journal-title":"Cancer"},{"issue":"1","key":"390_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0959-8049(01)00344-6","volume":"38","author":"K Kim","year":"2002","unstructured":"Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the REAL classification. Eur J Cancer. 2002;38(1):75\u201381. doi: 10.1016\/S0959-8049(01)00344-6 .","journal-title":"Eur J Cancer"},{"issue":"2","key":"390_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/1042819021000030054","volume":"44","author":"ER Arrowsmith","year":"2003","unstructured":"Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, et al. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American Lymphoma Classification. Leuk Lymphoma. 2003;44(2):241\u20139. doi: 10.1080\/1042819021000030054 .","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"390_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al. Non-Hodgkin\u2019s Lymphoma Classification Project: peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma) results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 2002;13(1):140\u20139. doi: 10.1093\/annonc\/mdf033 .","journal-title":"Ann Oncol"},{"issue":"5","key":"390_CR22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361\u201392.","journal-title":"Blood"},{"issue":"2","key":"390_CR23","first-page":"171","volume":"82","author":"F Zaja","year":"1997","unstructured":"Zaja F, Russo D, Silvestri F, Fanin R, Damiani D, Infanti L, et al. Retrospective analysis of 23 cases with peripheral T-cell lymphomas, unspecified: clinical characteristics and outcome. Haematologica. 1997;82(2):171\u20137.","journal-title":"Haematologica"},{"issue":"2","key":"390_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/107327480701400208","volume":"14","author":"D Rezania","year":"2007","unstructured":"Rezania D, Cualing HD, Ayala E. The diagnosis, management, and role of hematopoietic stem cell transplantation in aggressive peripheral T-cell neoplasms. Cancer Control. 2007;14(2):151\u20139. doi: 10.1007\/978-1-59745-224-3 .","journal-title":"Cancer Control"},{"issue":"11","key":"390_CR25","first-page":"577","volume":"21","author":"W Yong","year":"2000","unstructured":"Yong W, Zhang Y, Zheng W. The efficacy of l-asparaginase in the treatment of refractory midline peripheral T-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi. 2000;21(11):577\u20139.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0390-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0390-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T22:38:12Z","timestamp":1590100692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0390-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0390-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,2]]}}}